SERA 6.54 (+7.04%)
US81749D1072• Medical Diagnostics & Research• Diagnostics & Research
Intro Numbers Peers
  1. Home
  2. /
  3. All Stocks
  4. /
  5. SERA

Sera Prognostics (SERA) Competitor Comparison

We are evaluating the key criteria listed to compare Sera Prognostics (SERA) against its competitors in the Diagnostics & Research industry.

Market Capitalization

39 / 58

Gross Profits

51 / 52

Total Revenue

54 / 57

EBITDA

43 / 56

Free Cashflow

41 / 56

Quick Ratio

21 / 57

Earnings per Share

33 / 56

Dividend yield

0 / 9

Total Cash

40 / 57

Performance 3 years

25 / 58

Performance 5 years

39 / 58

Performance 10 years

38 / 58

Linearity 3 years

27 / 58

Linearity 5 years

36 / 58

Linearity 10 years

21 / 58

Total Rank

49 / 58

Dividend Rank

33 / 58

Valuation Rank

46 / 58

Piotroski Rank

45 / 58

Muliplier Rank

33 / 58

Linearity 10 years - SERA ranking 21 / 58

These are the competitors of Sera Prognostics in the industry Diagnostics & Research ranked by linearity 10 years
1. Guardant Health GH
109.74
2. Ortho Clinical Diagnostics Holdings OCDX
33.4
3. Neogen NEOG
25.98
4. National Research NRC
14.5
5. Inotiv NOTV
11.67
6. Illumina ILMN
11.46
7. Olink Holding OLK
8.11
8. Anixa Biosciences ANIX
6.95
9. Fulgent Genetics FLGT
6.61
10. Global Cord Blood CO
5.67
11. DarioHealth DRIO
4.86
12. Pacific Biosciences of California PACB
4.36
13. Myriad Genetics MYGN
3.98
14. Syneos Health SYNH
3.71
15. Sotera Health SHC
3.53
16. Qiagen QGEN
3.48
17. Exact Sciences EXAS
3.31
18. Bioventus BVS
3.2
19. Co-Diagnostics CODX
3.19
20. Enzo Biochem ENZ
3.08
21. Sera Prognostics SERA
2.81
22. Twist Bioscience TWST
2.77
23. Psychemedics PMD
2.74
24. Exagen XGN
2.32
25. Aspira Womens Health AWH
2.28
26. NeoGenomics NEO
2.25
27. Meridian Bioscience VIVO
2.1
28. MaxCyte MXCT
2.03
29. MDxHealth MDXH
1.99
30. CareDx CDNA
1.97
31. Biodesix BDSX
1.91
32. Personalis PSNL
1.88
33. Prenetics Global PRE
1.8
34. Organovo Holdings ONVO
1.66
35. Neuronetics STIM
1.62
36. Charles River Laboratories CRL
1.61
37. bioAffinity Technologies BIAF
1.58
38. Trinity Biotech TRIB
1.57
39. SeqLL SQL
1.42
40. Interpace Biosciences IDXG
1.29
41. Quest Diagnostics DGX
1.26
42. Laboratory Corp of America Holdings LH
1.18
43. PerkinElmer PKI
1.15
44. DexCom DXCM
1.14
45. Icon ICLR
1.1
46. IQVIA Holdings IQV
1.1
47. Precipio PRPO
1.05
48. Agilent Technologies A
1.01
49. Mettler-Toledo MTD
0.88
50. Thermo Fisher Scientific TMO
0.82
51. IDEXX Laboratories IDXX
0.8
52. Waters WAT
0.8
53. Danaher DHR
0.69
54. Heska HSKA
0.52
55. RadNet RDNT
0.49
56. Natera NTRA
0.46
57. Lantheus Holdings LNTH
0.33
58. Medpace Holdings MEDP
0.22
Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.